Most Common Skin Cancers | Key Companies antKwest, Kartos Therapeutics, Incyte Corporation, Bristol Myers Squibb, Nektar, and Immutep
Skin Cancer today is one of the major causes of mortality, years of life lost, and disability worldwide, which consequently affects the health outcome and the quality of life of the patients and their families. As per the WHO, one in every three cancers diagnosed is skin cancer. In the US, skin cancer is one of the most common types of cancer, and every year more than 3 million Americans are diagnosed with it.
Basal Cell Carcinoma, Squamous Cell Carcinoma, Merkel Cell Cancer, and Melanoma are some of the most common skin cancers worldwide. While, Kaposi sarcoma (KS), Actinic keratosis, Lymphoma of the skin, Keratoacanthoma are rare skin cancers. Currently, some of the key companies in Skin Cancer market focussing to offer potential treatment options includes Pellepharm, Medivir, Regeneron/Sanofi, Morphogenesis, NantKwest, Kartos Therapeutics, Incyte Corporation, Bristol Myers Squibb, Nektar, Immutep, Partner Therapeutics, Idera Pharmaceuticals, Oncolys BioPharma, Iovance Biotherapeutics, Hemispherx Biopharma, Infinity Pharmaceuticals, Spring Bank Pharmaceuticals, and others.
For more information, visit: Most Common Skin Cancers